An Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation
Molecular Cell · 2023-07 · 83 (13) · 2367-2386.e15
DOI: 10.1016/j.molcel.2023.05.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2023-07. Verfasst von Stephanie Pei Tung Yiu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Brigham and Women's Hospital, 181 Longwood Avenue, Boston, MA 02115, USA; Harvard Graduate Program in Virology, Bost…. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHGRI NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Epstein-Barr virus (EBV) causes infectious mononucleosis, triggers multiple sclerosis, and is associated with 200,000 cancers/year. EBV colonizes the human B cell compartment and periodically reactivates, inducing expression of 80 viral proteins. However, much remains unknown about how EBV remodels host cells and dismantles key antiviral responses. We therefore created a map of EBV-host and EBV-EBV interactions in B cells undergoing EBV replication, uncovering conserved herpesvirus versus EBV-specific host cell targets. The EBV-encoded G-protein-coupled receptor BILF1 associated with MAVS and the UFM1 E3 ligase UFL1. Although UFMylation of 14-3-3 proteins drives RIG-I/MAVS signaling, BILF1-directed MAVS UFMylation instead triggered MAVS packaging into mitochondrial-derived vesicles and lysosomal proteolysis. In the absence of BILF1, EBV replication activated the NLRP3 inflammasome, which impaired viral replication and triggered pyroptosis. Our results provide a viral protein interaction network resource, reveal a UFM1-dependent pathway for selective degradation of mitochondrial cargo, and highlight BILF1 as a novel therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Brigham and Women's Hospital, 181 Longwood Avenue, Boston, MA 02115, USA; Harvard Graduate Program in Virology, Boston, MA 02115, USA; Center for Integrated Solutions to Infectious Disea…
- Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK.
- Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
- Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK. Electronic address: mpw1001@cam.ac.uk.
Förderung
- NIAID NIH HHS
- NHGRI NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- Wellcome Trust
- Medical Research Council
- NIAID
- National Cancer Institute
Zitieren
APA
Yiu, S. P. T., Zerbe, C., Vanderwall, D., Huttlin, E. L., Weekes, M. P., & Gewurz, B. E. (2023). An Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation. Molecular Cell, 83(13), 2367-2386.e15. https://doi.org/10.1016/j.molcel.2023.05.018
Vancouver
Yiu SPT, Zerbe C, Vanderwall D, Huttlin EL, Weekes MP, Gewurz BE. An Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation. Molecular Cell. 2023;83(13):2367-2386.e15. doi:10.1016/j.molcel.2023.05.018
BibTeX
@article{Yiu2023,
author = {Yiu, Stephanie Pei Tung and Zerbe, Cassie and Vanderwall, David and Huttlin, Edward L and Weekes, Michael P and Gewurz, Benjamin E},
title = {An Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation},
journal = {Molecular Cell},
year = {2023},
volume = {83},
number = {13},
pages = {2367--2386.e15},
doi = {10.1016/j.molcel.2023.05.018}
}
EUVIMED